Pascal Odou
Overview
Explore the profile of Pascal Odou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
146
Citations
523
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Niot C, Cuvelier E, Leroy A, Vaiva G, Maron M, Cottencin O, et al.
Encephale
. 2025 Mar;
PMID: 40089436
Objectives: Medication compliance in lithium-treated patients is poor (43-46%) and may be responsible for relapse or toxicity. Improving understanding of treatment principles leads to increased medication adherence. To do this,...
2.
Moreau C, Odou P, Labreuche J, Demailly A, Touzet G, Reyns N, et al.
Nat Med
. 2025 Jan;
PMID: 39775041
Continuous compensation for cerebral dopamine deficiency represents an ideal treatment for Parkinson's disease. Dopamine does not cross the digestive and blood-brain barriers and is rapidly oxidized. The new concept is...
3.
Deramoudt L, Pinturaud M, Bouquet P, Goffard A, Simon N, Odou P
Occup Environ Med
. 2024 Dec;
81(12):615-621.
PMID: 39632065
Objective: The objective of the present study was to develop a method for sampling and detecting an adenovirus-derived gene therapy (GT) vector on isolator worksurfaces. Methods: We used a quantitative...
4.
Quinet F, Gilliot S, Beauvais D, Vasseur M, Srour M, Magro L, et al.
J Oncol Pharm Pract
. 2024 Nov;
:10781552241297391.
PMID: 39584735
Introduction: The general-purpose rating scales used by clinical pharmacists to rate their activities have not been extensively studied in specialist care units. This study aims to describe drug-related problems (DRPs)...
5.
Closset M, Colsoul M, Bihin B, Hecq J, Odou P, Galanti L
J Pharm Technol
. 2024 Nov;
40(6):296-299.
PMID: 39507876
Background: Closed system transfer devices (CSTD) help to reduce the exposure of healthcare professionals to hazardous drugs. They may be used in stability studies conducted on anticancer drugs. During a...
6.
Delporte L, Brianceau M, Rihani E, Masse M, Laueriere C, Odou P, et al.
Ann Pharm Fr
. 2024 Oct;
83(2):322-330.
PMID: 39461657
Objectives: Chronic total occlusion (CTO) of coronary arteries is defined as complete absence of antegrade coronary flow without iodine passage, since more than 3 months. Coronary revascularization is a highly...
7.
Freppel R, Barbier A, Dambrine M, Robert L, Rousseliere C, Cuneo E, et al.
Therapie
. 2024 Oct;
PMID: 39455303
Background: By recovering data in an ordered manner and at the right time, clinical decision support systems (CDSSs) are designed to help healthcare professionals make decisions that improve patient care....
8.
Negrier L, Decaudin B, Treizebre A, Guilbert M, Odou P, Martin Mena A
Pharmaceuticals (Basel)
. 2024 Sep;
17(9).
PMID: 39338384
Introduction: Drug incompatibilities are among the most common medication errors in intensive care units. A precipitate can form and block the catheter or cause an adverse event in the patient....
9.
Negrier L, Martin Mena A, Dupont C, Gamache P, Zimbril J, Abdoune Y, et al.
Pharmaceuticals (Basel)
. 2024 Aug;
17(8).
PMID: 39204190
Bacterial respiratory tract infections (e.g., in patients with cystic fibrosis) may be treated with the intravenous infusion of a piperacillin/tazobactam (P/T) solution through an elastomeric device. In the present work,...
10.
Robert L, Laraba A, Bruandet A, Royer A, Odou P, Decaudin B, et al.
Therapie
. 2024 Aug;
PMID: 39191598
Pharmacy decision support systems (PDSS) help clinical pharmacists to prevent and detect adverse drug events. The coding of hospital stays by the department of medical information (DMI) requires expertise, as...